ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.

about

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.

P2860

Q38758020-0E29E43F-37C7-48BF-8011-635CE526C358

P2860

ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.

Item

http://www.wikidata.org/entity/Q41109922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

ERG Is a Useful Immunohistoche ...... cytic Infiltrates in the Skin.

@en

type

Item

label

ERG Is a Useful Immunohistoche ...... cytic Infiltrates in the Skin.

@en

prefLabel

ERG Is a Useful Immunohistoche ...... cytic Infiltrates in the Skin.

@en

P1476

ERG Is a Useful Immunohistoche ...... cytic Infiltrates in the Skin.

@en

P2093

Daisy Naughton

http://www.w3.org/2001/XMLSchema#string

Klaus Busam

http://www.w3.org/2001/XMLSchema#string

Melissa Pulitzer

http://www.w3.org/2001/XMLSchema#string

P2860

The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells

Atlas of genetics and cytogenetics in oncology and haematology in 2013

Myeloid leukemia cutis: a histologic and immunohistochemical review.

Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.

Neutrophilic dermatoses: a review of current treatment options.

Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics.

Acute myeloid leukemia: a central role for the ETS factor ERG.

Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature.

Leukemia cutis - epidemiology, clinical presentation, and differential diagnoses.

P304

672-677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/DAD.0000000000000491

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bin Xu

Klaus Busam

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26909589

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5026187

http://www.w3.org/2001/XMLSchema#string

ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.

about

P2860

P2860

ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932